Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer

Norikatsu Miyoshi(Osaka International Cancer Institute), Shingi Imaoka(Osaka International Cancer Institute), Isao Miyashiro(Osaka International Cancer Institute), Yuichiro� Doki(Osaka Gakuin University), Osamu Ishikawa(Gunma University), Ko Takachi(Osaka Medical Center for Cancer and Cardiovascular Diseases), Hiroaki Ohigashi(Teine Keijinkai Hospital), Hidetoshi Eguchi(Osaka Gakuin University), Yo Sasaki(SHOWA Medical University), Terumasa Yamada, Kentaro Kishi(Osaka International Cancer Institute), Masahiko Yano(Nagoya Sangyo University), Shingo Noura(Osaka Rosai Hospital), Masayuki Ohue(Hyogo Medical University)
Journal of Surgical Oncology
January 23, 2009
Cited by 30


Related Papers